Historique de carrière de Georges Rawadi
Anciens postes connus de Georges Rawadi
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELYAD ONCOLOGY SA | Directeur/Membre du Conseil | 27/04/2023 | 01/12/2023 |
| Directeur Général | 27/04/2023 | 01/12/2023 | |
YSOPIA Biosciences SA
 YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Directeur/Membre du Conseil | 01/03/2018 | 01/09/2021 |
| Directeur Général | 01/03/2018 | 01/09/2021 | |
| CELYAD ONCOLOGY SA | Corporate Officer/Principal | 01/06/2014 | 23/03/2018 |
| CELLECTIS S.A. | Corporate Officer/Principal | - | - |
Formation de Georges Rawadi
| ESSEC Business School | Graduate Degree |
Statistiques
Internationale
| France | 5 |
| Belgique | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CELYAD ONCOLOGY SA | Health Technology |
| CELLECTIS S.A. | Health Technology |
| Entreprise privées | 2 |
|---|---|
| Université Pierre et Marie Curie | Consumer Services |
YSOPIA Biosciences SA
YSOPIA Biosciences SA BiotechnologyHealth Technology LNC Therapeutics SA operates as a research and development company that designs and develops medical food formulas. It's develop therapeutic solutions for metabolic and cardiometabolic disorders. The firm also designs and develops formulas for obesity and pre-diabetes sickness. Its products include Stablor, Bariamed, and Fertimed. It encompass serious game, patient community, and support tools: BariaSpoon and BariaFork. The company was founded by Jérôme Théron and Claude Vincent on October 29, 2010 and is headquartered in Bordeaux, France. | Health Technology |
- Bourse
- Insiders
- Georges Rawadi
- Expérience
